SLDB Solid Biosciences Inc. - Common Stock
$9.71
价格 · 八月 19, 2026
截至...的财报数据 八月 6, 2026
52周区间
$4–$11
77% of range
分析师评级
BUY
19 analysts
目标价
$18
+82% upside
P/E (TTM)
-4.9
ROE
-79.5%
净利润率
—
SLDB 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$9.71
市值
$766M
P/E (TTM)
-4.9
每股收益 (TTM)
$-1.99
营收 (TTM)
—
股息收益率
—
ROE
-79.5%
负债/权益
—
52周区间
$4 – $11
SLDB 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
2016-12-31
→
2022-12-31
EPS
$-1.99
2020-12-31
→
2025-12-31
自由现金流
$-157M
2018-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
SLDB
同行中位数
P/E (TTM)
-4.9
—
P/B (市净率)
4.3
3.4
Price / FCF (股价/自由现金流)
-4.9
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
SLDB
同行中位数
ROA
-82.8%
-31.3%
ROE
-79.5%
-38.1%
ROIC
-99.6%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
SLDB
同行中位数
Current Ratio (流动比率)
6.1
10.9
Quick Ratio (速动比率)
1.8
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
SLDB
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
SLDB
同行中位数
SLDB 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
19 位分析师
- 强烈买入 8 42.1%
- 买入 10 52.6%
- 持有 1 5.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
11 位分析师 · 2026-08-17
中位数
$16.00
平均值
$17.64
← 低于所有目标
$9.71
最低
$11.00
最高
$26.00
中位数目标
$16.00
+64.9%
平均目标
$17.64
+81.7%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.02%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.38 | $-0.48 | 0.10% |
| 2026年3月31日 | $-0.52 | $-0.44 | -0.08% |
| 2025年12月31日 | $-0.53 | $-0.53 | -0.00% |
| 2025年9月30日 | $-0.48 | $-0.45 | -0.03% |
| 2025年6月30日 | $-0.42 | $-0.51 | 0.09% |
| 2025年3月31日 | $-0.59 | $-0.57 | -0.02% |
| 2024年12月31日 | $-1.00 | $-0.82 | -0.18% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| SLDB | $445M | -2.8 | — | — | -79.5% | — |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | — |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | — |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | — |
| ANNX | $750M | -3.7 | — | — | -100.7% | — |
| GERN | $845M | -10.2 | -60.2% | — | -34.4% | — |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | — |
| CADL | $310M | -7.8 | — | — | -53.7% | — |
| DSGN | $567M | -7.7 | — | — | -32.8% | — |
| CLYM | $191M | -4.5 | — | — | -34.6% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $8M | $14M | $0 | $0 | $0 | $0 | |
| R&D Expense | $140M | $96M | $77M | $78M | $59M | $65M | $95M | $58M | $40M | |
| SG&A Expense | $39M | $33M | $28M | $29M | $27M | $22M | $25M | $18M | $15M | |
| Operating Expenses | $179M | $130M | $104M | $115M | $86M | $88M | $119M | $76M | $55M | |
| Operating Income | $-179M | $-130M | $-104M | $-106M | $-72M | $-88M | $-119M | $-76M | $-55M | |
| Interest Income | $10M | $9M | $8M | $3M | $64.0K | $115.0K | $2M | $619.0K | $219.0K | |
| Other Non-op | $824.0K | $652.0K | $1M | $-381.0K | $2.0K | $1.0K | $515.0K | $270.0K | $1M | |
| Pretax Income | $-174M | $-125M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-174M | $-125M | $-96M | $-86M | $-72M | $-88M | $-117M | $-75M | $-52M | |
| EPS (Basic) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | · | · | · | |
| EPS (Diluted) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | · | · | · | |
| Shares (Basic) | 87,504,631 | 40,816,694 | 19,884,007 | 8,512,089 | 7,118,024 | 3,462,475 | · | · | · | |
| Shares (Diluted) | 87,504,631 | 40,816,694 | 19,884,007 | 8,512,089 | 7,118,024 | 3,462,475 | · | · | · | |
| EBITDA | $-179M | $-130M | $-104M | $-106M | $-72M | $-88M | · | $-76M | · |
资产负债表 21
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $80M | $74M | $155M | $119M | $155M | $76M | $86M | $52M | |
| Short-term Investments | · | · | · | · | · | · | · | $36M | $17M | |
| Prepaid Expense | $16M | $8M | $6M | $6M | $15M | $4M | $3M | $6M | $1M | |
| Current Assets | $205M | $157M | $130M | $220M | $223M | $159M | $86M | $129M | $71M | |
| PP&E (Net) | $4M | $5M | $7M | $10M | $6M | $8M | $12M | $10M | $2M | |
| PP&E (Gross) | $18M | $18M | $19M | $21M | $18M | $17M | $16M | $12M | $3M | |
| Accum. Depreciation | $14M | $13M | $13M | $11M | $12M | $9M | $5M | $2M | $504.0K | |
| Other Non-current Assets | $223.0K | $366.0K | $209.0K | $175.0K | $94.0K | $209.0K | $209.0K | $209.0K | · | |
| Total Assets | $233M | $189M | $165M | $260M | $232M | $171M | $103M | $140M | $76M | |
| Accounts Payable | $3M | $4M | $2M | $3M | $4M | $3M | $7M | $4M | $5M | |
| Accrued Liabilities | $19M | $20M | $10M | $17M | $10M | $9M | $9M | $8M | $6M | |
| Current Liabilities | $33M | $30M | $15M | $23M | $24M | $24M | $18M | $12M | $11M | |
| Capital Leases | $19M | $21M | $23M | $24M | $275.0K | $2M | $4M | $859.0K | · | |
| Other Non-current Liabilities | · | · | · | $96.0K | · | $1M | · | $1M | · | |
| Total Liabilities | $53M | $51M | $38M | $49M | $24M | $39M | $23M | $14M | $11M | |
| Common Stock | $79.0K | $40.0K | $20.0K | $20.0K | $7.0K | $87.0K | $48.0K | $35.0K | · | |
| Retained Earnings | $-958M | $-783M | $-659M | $-563M | $-477M | $-405M | $-316M | $-199M | $-124M | |
| AOCI | $52.0K | $47.0K | $15.0K | $-68.0K | $-45.0K | $0 | $1.0K | $-5.0K | $-13.0K | |
| Stockholders' Equity | $180M | $137M | $126M | $212M | $208M | $132M | $80M | $125M | $-59M | |
| Liabilities + Equity | $233M | $189M | $165M | $260M | $232M | $171M | $103M | $140M | $76M | |
| Shares Outstanding | 78,967,888 | 40,468,141 | 20,386,606 | 19,556,732 | 7,356,017 | 84,893,994 | 45,987,571 | 35,432,460 | 0 |
现金流 11
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $2M | $3M | $4M | $3M | · | · | |
| Stock-based Comp | $17M | $11M | $8M | $8M | $13M | $12M | $14M | $6M | $5M | |
| Restructuring | · | · | $-63.0K | $7M | · | $2M | · | · | · | |
| Operating Cash Flow | $-156M | $-100M | $-94M | $-98M | $-78M | $-57M | $-93M | $-70M | $-43M | |
| CapEx | $1M | $654.0K | $2M | $3M | $1M | $899.0K | $4M | $8M | $2M | |
| Investing Cash Flow | $-58M | $-16M | $10M | $59M | $-91M | $7M | $25M | $-27M | $10M | |
| Stock Issued | · | · | $3M | $73M | $135M | $113M | $49M | · | · | |
| Net Stock Activity | · | · | $3M | $73M | $135M | $113M | · | · | · | |
| Financing Cash Flow | $194M | $122M | $3M | $75M | $135M | $129M | $58M | $132M | $77M | |
| Net Change in Cash | $-20M | $6M | $-81M | $36M | $-34M | $79M | $-10M | $35M | $44M | |
| Free Cash Flow | $-157M | $-101M | $-96M | $-101M | $-79M | $-57M | · | $-78M | · |
盈利能力 6
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -1315.2% | -530.5% | · | · | · | · | |
| Net Margin | · | · | · | -1062.3% | -530.0% | · | · | · | · | |
| EBITDA Margin | · | · | · | -1315.2% | -530.5% | · | · | · | · | |
| ROA | -82.8% | -70.5% | -45.2% | -34.9% | -35.8% | -64.3% | · | -69.3% | · | |
| ROE | -79.5% | -82.0% | -70.9% | -48.4% | -33.5% | -114.4% | · | -55.4% | · | |
| ROIC | -99.6% | · | · | · | · | · | · | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 5.2 | 8.9 | 9.8 | 9.4 | 6.5 | · | 10.3 | · | |
| Quick Ratio | 1.8 | 2.7 | 5.1 | 6.9 | 5.0 | 6.3 | · | 6.9 | · |
效率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | 0.0 | · | 0.0 | · |
增长率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -40.6% | · | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $8M | $14M | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-174M | $-125M | $-96M | $-86M | $-72M | $-88M | $-117M | $-75M | $-52M | |
| Market Cap | $445M | $162M | $125M | $105M | $2.90B | $9.65B | · | $14.24B | · | |
| P/E | -2.8 | -1.3 | -1.3 | -0.5 | -2.6 | -4.5 | · | · | · | |
| P/S | · | · | · | 13.0 | 212.7 | · | · | · | · | |
| P/B | 2.5 | 1.2 | 1.0 | 0.5 | 13.9 | 73.1 | · | 113.8 | · | |
| P / Tangible Book | 2.5 | 1.2 | 1.0 | 0.5 | 13.9 | 73.1 | · | · | · | |
| P / Cash Flow | -2.8 | -1.6 | -1.3 | -1.1 | -37.2 | -170.5 | · | -202.9 | · | |
| P / FCF | -2.8 | -1.6 | -1.3 | -1.0 | -36.6 | -167.9 | · | -182.7 | · | |
| Earnings Yield | -35.3% | -76.5% | -78.7% | -187.7% | -38.6% | -22.4% | · | · | · |
损益表 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $44M | $46M | $38M | $39M | $32M | $31M | $31M | $27M | $19M | $19M | $15M | $17M | $20M | $25M | $21M | $14M | |
| SG&A Expense | $13M | $11M | $11M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $6M | $7M | $7M | $8M | $7M | |
| Operating Expenses | $57M | $57M | $49M | $48M | $42M | $40M | $40M | $35M | $28M | $27M | $22M | $23M | $27M | $32M | $35M | $21M | |
| Operating Income | $-57M | $-57M | $-49M | $-48M | $-42M | $-40M | $-40M | $-35M | $-28M | $-27M | $-22M | $-23M | $-27M | $-32M | $-35M | $-21M | |
| Interest Expense | · | · | · | · | · | · | · | · | $88.0K | $95.0K | · | · | $111.0K | $121.0K | · | · | |
| Interest Income | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $735.0K | |
| Other Non-op | $214.0K | $157.0K | $219.0K | $210.0K | $207.0K | $188.0K | $199.0K | $211.0K | $239.0K | $3.0K | $270.0K | $278.0K | $265.0K | $282.0K | $-355.0K | $-13.0K | |
| Income Tax | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-55M | $-57M | $-50M | $-46M | $-39M | $-39M | $-43M | $-33M | $-25M | $-24M | $-20M | $-21M | $-25M | $-30M | $-15M | $-20M | |
| EPS (Basic) | $-0.38 | $-0.52 | $-0.50 | $-0.48 | $-0.42 | $-0.59 | $-1.02 | $-0.79 | $-0.61 | $-0.64 | $-0.99 | $-1.05 | $-1.25 | $-1.54 | $-0.69 | $-2.71 | |
| EPS (Diluted) | $-0.38 | $-0.52 | $-0.67 | $-0.48 | $-0.42 | $-0.59 | $-1.02 | $-0.79 | $-0.61 | $-0.64 | $-0.99 | $-1.05 | $-1.25 | $-1.54 | $-0.69 | $-2.71 | |
| Shares (Basic) | 143,688,701 | 109,811,461 | -167,394,706 | 94,417,746 | 94,140,286 | 66,341,305 | -79,716,357 | 41,443,317 | 40,934,361 | 38,155,373 | -39,406,941 | 20,059,641 | 19,663,672 | 19,567,635 | -14,051,736 | 7,532,706 | |
| Shares (Diluted) | 143,688,701 | 109,811,461 | -167,394,706 | 94,417,746 | 94,140,286 | 66,341,305 | -79,716,357 | 41,443,317 | 40,934,361 | 38,155,373 | -39,406,941 | 20,059,641 | 19,663,672 | 19,567,635 | -14,051,736 | 7,532,706 | |
| EBITDA | $-57M | $-57M | · | $-48M | $-42M | $-40M | · | $-35M | $-28M | $-27M | · | $-23M | $-27M | $-32M | · | $-21M |
资产负债表 20
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $159M | $297M | $60M | $61M | $139M | $211M | $80M | $64M | $96M | $118M | $74M | $49M | $92M | $165M | $155M | $49M | |
| Prepaid Expense | $17M | $15M | $16M | $9M | $11M | $6M | $8M | $8M | $7M | $8M | $6M | $5M | $7M | $5M | $6M | $5M | |
| Current Assets | $395M | $397M | $205M | $245M | $279M | $313M | $157M | $179M | $198M | $214M | $130M | $148M | $167M | $191M | $220M | $148M | |
| PP&E (Net) | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $6M | $7M | $7M | $7M | $9M | $10M | $6M | |
| PP&E (Gross) | · | · | $18M | · | · | · | $18M | · | · | $19M | $19M | $19M | $19M | $19M | $21M | $16M | |
| Accum. Depreciation | · | · | $14M | · | · | · | $13M | · | · | $13M | $13M | $12M | $12M | $11M | $11M | $9M | |
| Other Non-current Assets | $138.0K | $183.0K | $223.0K | $247.0K | $278.0K | $319.0K | $366.0K | $475.0K | $515.0K | $175.0K | $209.0K | $315.0K | $181.0K | $238.0K | $175.0K | $422.0K | |
| Total Assets | $421M | $423M | $233M | $274M | $308M | $344M | $189M | $212M | $231M | $249M | $165M | $185M | $205M | $230M | $260M | $184M | |
| Accounts Payable | $4M | $6M | $3M | $8M | $5M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $3M | $6M | $3M | $5M | |
| Accrued Liabilities | $18M | $19M | $19M | $19M | $17M | $15M | $20M | $13M | $10M | $10M | $10M | $11M | $11M | $12M | $17M | $10M | |
| Current Liabilities | $29M | $30M | $33M | $36M | $30M | $29M | $30M | $23M | $15M | $14M | $15M | $16M | $16M | $20M | $23M | $17M | |
| Capital Leases | $18M | $18M | $19M | $20M | $20M | $21M | $21M | $22M | $22M | $23M | $23M | $23M | $24M | $24M | $24M | $24M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $96.0K | · | |
| Total Liabilities | $47M | $49M | $53M | $56M | $50M | $49M | $51M | $45M | $38M | $38M | $38M | $40M | $41M | $46M | $49M | $41M | |
| Common Stock | $105.0K | $98.0K | $79.0K | $78.0K | $78.0K | $77.0K | $40.0K | $39.0K | $39.0K | $38.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $8.0K | |
| Retained Earnings | $-1.07B | $-1.01B | $-958M | $-908M | $-862M | $-823M | $-783M | $-741M | $-708M | $-683M | $-659M | $-638M | $-617M | $-593M | $-563M | $-548M | |
| AOCI | $-113.0K | $-13.0K | $52.0K | $48.0K | $-38.0K | $2.0K | $47.0K | $116.0K | $-15.0K | $-4.0K | $15.0K | $2.0K | $14.0K | $5.0K | $-68.0K | $-196.0K | |
| Stockholders' Equity | $374M | $374M | $180M | $218M | $258M | $294M | $137M | $167M | $193M | $211M | $126M | $144M | $164M | $184M | $212M | $143M | |
| Liabilities + Equity | $421M | $423M | $233M | $274M | $308M | $344M | $189M | $212M | $231M | $249M | $165M | $185M | $205M | $230M | $260M | $184M | |
| Shares Outstanding | 105,125,366 | 98,394,720 | 78,967,888 | 77,882,685 | 77,602,741 | 77,492,959 | 40,468,141 | 38,930,203 | 38,551,059 | 37,833,689 | 20,386,606 | 20,061,751 | 20,044,389 | 19,573,132 | 19,556,732 | 7,533,081 |
现金流 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $391.0K | $395.0K | $467.0K | $376.0K | $386.0K | $407.0K | $488.0K | $405.0K | $1M | $327.0K | · | · | · | · | · | · | |
| Stock-based Comp | $6M | $5M | $6M | $4M | $3M | $3M | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $-63.0K | · | $6M | $0 | |
| Operating Cash Flow | $-53M | $-47M | $-54M | $-33M | $-37M | $-32M | $-30M | $-24M | $-21M | $-25M | $-21M | $-18M | $-27M | $-28M | $-34M | $-20M | |
| CapEx | $150.0K | $165.0K | $565.0K | $85.0K | $377.0K | $126.0K | $204.0K | $15.0K | $286.0K | $149.0K | $90.0K | $383.0K | $536.0K | $506.0K | $856.0K | $839.0K | |
| Investing Cash Flow | $-134M | $45M | $47M | $-45M | $-33M | $-27M | $39M | $-11M | $-5M | $-38M | $45M | $-25M | $-48M | $37M | $66M | $15M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $48M | $239M | $5M | $1M | $-2M | $190M | $7M | $3M | $5M | $107M | $505.0K | $0 | · | · | $75M | $-1.0K | |
| Net Change in Cash | $-138M | $237M | $-1M | $-78M | $-72M | $130M | $16M | $-31M | $-22M | $44M | $25M | $-43M | $-73M | $9M | $106M | $-6M | |
| Free Cash Flow | · | $-47M | · | · | · | $-32M | · | · | · | $-25M | · | · | · | $-29M | · | · |
盈利能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -15.0% | -14.8% | · | -18.9% | -14.6% | -13.3% | · | -16.5% | -11.5% | -10.2% | · | -11.4% | -11.9% | -13.8% | · | -9.4% | |
| ROE | -17.3% | -17.0% | · | -23.8% | -17.5% | -15.6% | · | -21.0% | -14.1% | -12.3% | · | -14.6% | -15.1% | -16.3% | · | -11.1% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.8 | 13.1 | · | 6.7 | 9.3 | 10.9 | · | 7.9 | 13.5 | 14.9 | · | 9.4 | 10.6 | 9.4 | · | 8.7 | |
| Quick Ratio | 5.6 | 9.8 | · | 1.7 | 4.7 | 7.3 | · | 2.8 | 6.5 | 8.2 | · | 3.1 | 5.8 | 8.1 | · | 2.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -315.8 | -282.8 | · | · | · | · | · | · |
估值 (TTM) 9
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-197M | $-181M | · | $-157M | $-137M | $-121M | · | $-103M | $-95M | $-100M | · | $-96M | $-100M | $-101M | · | $-89M | |
| Market Cap | $1.05B | $708M | · | $481M | $378M | $287M | · | $271M | $219M | $504M | · | $51M | $105M | $93M | · | $53M | |
| P/E | -5.5 | -3.6 | · | -2.9 | -2.2 | -1.5 | · | -2.3 | -1.6 | -3.0 | · | -0.4 | -0.6 | -0.4 | · | -0.6 | |
| P/B | 2.8 | 1.9 | · | 2.2 | 1.5 | 1.0 | · | 1.6 | 1.1 | 2.4 | · | 0.4 | 0.6 | 0.5 | · | 0.4 | |
| P / Tangible Book | 2.8 | 1.9 | · | 2.2 | 1.5 | 1.0 | · | 1.6 | 1.1 | 2.4 | · | 0.4 | 0.6 | 0.5 | · | 0.4 | |
| P / Cash Flow | · | -15.0 | · | · | · | -9.0 | · | · | · | -20.0 | · | · | · | -3.3 | · | · | |
| P / FCF | · | -14.9 | · | · | · | -9.0 | · | · | · | -19.9 | · | · | · | -3.3 | · | · | |
| Earnings Yield | -18.0% | -27.9% | · | -34.2% | -46.0% | -66.5% | · | -44.3% | -62.6% | -33.6% | · | -259.9% | -168.5% | -231.0% | · | -168.6% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | — | — | — | $8M | $14M |
| 营业利润率 % | — | — | — | -1315.2% | -530.5% |
| 净收入 | $-174M | $-125M | $-96M | $-86M | $-72M |
| 稀释后每股收益 (EPS) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 6.1 | 5.2 | 8.9 | 9.8 | 9.4 |
| 速动比率 | 1.8 | 2.7 | 5.1 | 6.9 | 5.0 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-157M | $-101M | $-96M | $-101M | $-79M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 167 家申报者 · $974.0M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 44 (+7 与上一季度对比) | 25 (+13 与上一季度对比) | 53 (0 与上一季度对比) | 39 (-1 与上一季度对比) | +6.6M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $120240899 | 12036126 | 12.34% | 股份 |
| PERCEPTIVE ADVISORS LLC | $118947393 | 11906646 | 12.21% | 股份 |
| Bain Capital Life Sciences Investors, LLC | $97990102 | 9808819 | 10.06% | 股份 |
| Siren, L.L.C. | $76827146 | 7690405 | 7.89% | 股份 |
| FMR LLC | $46864419 | 4691133 | 4.81% | 股份 |
| ARMISTICE CAPITAL, LLC | $42737220 | 4278000 | 4.39% | 股份 |
| STATE STREET CORP | $41711896 | 4175365 | 4.28% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $40059121 | 4009922 | 4.11% | 股份 |
| RTW INVESTMENTS, LP | $38890331 | 3892926 | 3.99% | 股份 |
| Deep Track Capital, LP | $35614969 | 3565062 | 3.66% | 股份 |
| JANUS HENDERSON GROUP PLC | $28877004 | 4010695 | 2.96% | 股份 |
| CITADEL ADVISORS LLC | $24560285 | 2458487 | 2.52% | 股份 |
| Alyeska Investment Group, L.P. | $22782035 | 2280484 | 2.34% | 股份 |
| Vestal Point Capital, LP | $21578400 | 2160000 | 2.22% | 股份 |
| AMERIPRISE FINANCIAL INC | $20575205 | 2059578 | 2.11% | 股份 |
| Redmile Group, LLC | $19467463 | 1948695 | 2.00% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $16645589 | 1665937 | 1.71% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $15049995 | 1506506 | 1.55% | 股份 |
| GOLDMAN SACHS GROUP INC | $14106819 | 1412094 | 1.45% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $11524834 | 1153637 | 1.18% | 股份 |
| BLAIR WILLIAM & CO/IL | $7555207 | 756277 | 0.78% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7478404 | 748589 | 0.77% | 股份 |
| Woodline Partners LP | $6734019 | 674076 | 0.69% | 股份 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $6677816 | 668450 | 0.69% | 股份 |
| Birchview Capital, LP | $6655298 | 666196 | 0.68% | 股份 |
| MOORE CAPITAL MANAGEMENT, LP | $6028685 | 603472 | 0.62% | 股份 |
| Monashee Investment Management LLC | $4995000 | 500000 | 0.51% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $4942353 | 494730 | 0.51% | 股份 |
| Point72 Asset Management, L.P. | $4475600 | 448008 | 0.46% | 股份 |
| STEMPOINT CAPITAL LP | $3584212 | 358780 | 0.37% | 股份 |
| Boxer Capital Management, LLC | $2997000 | 300000 | 0.31% | 股份 |
| Ally Bridge Group (NY) LLC | $2557030 | 255959 | 0.26% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2441566 | 244401 | 0.25% | 股份 |
| J. Goldman & Co LP | $2419218 | 242164 | 0.25% | 股份 |
| D. E. Shaw & Co., Inc. | $2225662 | 222789 | 0.23% | 股份 |
| BANK OF AMERICA CORP /DE/ | $2040777 | 204282 | 0.21% | 股份 |
| UBS Group AG | $1881587 | 188347 | 0.19% | 股份 |
| ALGERT GLOBAL LLC | $1872316 | 187419 | 0.19% | 股份 |
| Balyasny Asset Management L.P. | $1780747 | 178253 | 0.18% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1628740 | 163037 | 0.17% | 股份 |
| Apis Capital Advisors, LLC | $1598400 | 160000 | 0.16% | 股份 |
| Soleus Capital Management, L.P. | $1498500 | 150000 | 0.15% | 股份 |
| CITIGROUP INC | $1437471 | 143891 | 0.15% | 股份 |
| Qube Research & Technologies Ltd | $1367661 | 136903 | 0.14% | 股份 |
| BlackRock, Inc. | $1293865 | 129516 | 0.13% | 股份 |
| Y-Intercept (Hong Kong) Ltd | $1097761 | 109886 | 0.11% | 股份 |
| Bank of New York Mellon Corp | $1081707 | 108279 | 0.11% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $1081038 | 108212 | 0.11% | 股份 |
| Susquehanna Portfolio Strategies, LLC | $1071717 | 107279 | 0.11% | 股份 |
| RHUMBLINE ADVISERS | $1049627 | 105068 | 0.11% | 股份 |
| Fisher Asset Management, LLC | $1033775 | 103481 | 0.11% | 股份 |
| GOLDMAN SACHS GROUP INC | $999000 | 100000 | 0.10% | 买入期权 |
| ALPS ADVISORS INC | $998161 | 99916 | 0.10% | 股份 |
| XTX Topco Ltd | $889450 | 89034 | 0.09% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $820179 | 82100 | 0.08% | 股份 |
| Verition Fund Management LLC | $811937 | 81275 | 0.08% | 股份 |
| Quadrature Capital Ltd | $782117 | 78290 | 0.08% | 股份 |
| Quantum Private Wealth, LLC | $738241 | 73898 | 0.08% | 股份 |
| Rafferty Asset Management, LLC | $717072 | 71779 | 0.07% | 股份 |
| Trexquant Investment LP | $690589 | 69128 | 0.07% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $621488 | 62211 | 0.06% | 股份 |
| JANE STREET GROUP, LLC | $617242 | 61786 | 0.06% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $606443 | 60705 | 0.06% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $586313 | 58690 | 0.06% | 股份 |
| Vanguard Global Advisers, LLC | $585324 | 58591 | 0.06% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $575604 | 57618 | 0.06% | 股份 |
| Knott David M Jr | $561518 | 56208 | 0.06% | 股份 |
| BARCLAYS PLC | $552167 | 55272 | 0.06% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $498672 | 69260 | 0.05% | 股份 |
| BANK OF NOVA SCOTIA | $471538 | 47201 | 0.05% | 股份 |
| MetLife Investment Management, LLC | $461108 | 46157 | 0.05% | 股份 |
| Virtus Investment Advisers, LLC | $457802 | 45826 | 0.05% | 股份 |
| DeepCurrents Investment Group LLC | $447832 | 44828 | 0.05% | 股份 |
| Ikarian Capital, LLC | $429130 | 42956 | 0.04% | 股份 |
| Quantinno Capital Management LP | $400999 | 40140 | 0.04% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $373626 | 37400 | 0.04% | 买入期权 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $368831 | 36920 | 0.04% | 股份 |
| PROFUND ADVISORS LLC | $365065 | 36543 | 0.04% | 股份 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $361998 | 36236 | 0.04% | 股份 |
| Creative Planning | $358241 | 35860 | 0.04% | 股份 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | $332577 | 33291 | 0.03% | 股份 |
| ArchPoint Investors | $312947 | 31326 | 0.03% | 股份 |
| Invesco Ltd. | $308891 | 30920 | 0.03% | 股份 |
| CITADEL ADVISORS LLC | $308691 | 30900 | 0.03% | 买入期权 |
| Engineers Gate Manager LP | $288861 | 28915 | 0.03% | 股份 |
| HSBC HOLDINGS PLC | $285269 | 27804 | 0.03% | 股份 |
| Atom Investors LP | $271548 | 27182 | 0.03% | 股份 |
| Police & Firemen's Retirement System of New Jersey | $231868 | 23210 | 0.02% | 股份 |
| SFMG, LLC | $221308 | 22153 | 0.02% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $212218 | 21243 | 0.02% | 股份 |
| VANGUARD GROUP INC | $205307 | 36402 | 0.02% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $199291 | 19949 | 0.02% | 股份 |
| AXQ CAPITAL, LP | $197193 | 19739 | 0.02% | 股份 |
| CIBC Private Wealth Group LLC | $188802 | 30600 | 0.02% | 股份 |
| Skopos Labs, Inc. | $185840 | 25811 | 0.02% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $169830 | 17000 | 0.02% | 股份 |
| INTECH INVESTMENT MANAGEMENT LLC | $162857 | 16302 | 0.02% | 股份 |
| Lido Advisors, LLC | $159700 | 15986 | 0.02% | 股份 |
| China Universal Asset Management Co., Ltd. | $156523 | 15668 | 0.02% | 股份 |
| VOYA INVESTMENT MANAGEMENT LLC | $156084 | 15624 | 0.02% | 股份 |
公司内部人士 29 位内幕人士 · 13 位高管 · 14 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Alexander Cumbo | President and CEO | 2026年1月29日 A | 235405 | 0 | 4 | $-983959 |
| Kevin Tan | CFO & Treasurer | 2026年1月29日 A | 99422 | 0 | 4 | $-329544 |
| Jennifer Lynn Ziolkowski | CFO, Treasurer & Asst. Secy | 2021年1月27日 M | 335636 | 0 | 0 | $0 |
| David T Howton | Chief Operating Officer | 2026年1月29日 A | 105077 | 0 | 4 | $-433595 |
| Pedro Alvaro Amorrortu | Chief Operating Officer | 2019年1月23日 A | 162746 | 0 | 0 | $0 |
| Gabriel Brooks | Chief Medical Officer | 2026年1月29日 A | 89466 | 0 | 3 | $-280978 |
| Paul Herzich | Chief Technology Officer | 2026年1月29日 A | 72638 | 0 | 4 | $-274125 |
| Jessie Hanrahan | Chief Regulatory Officer | 2026年1月29日 A | 74318 | 0 | 4 | $-297374 |
| Jennifer Marlowe | CSO | 2024年2月13日 A | 6998 | 0 | 0 | $0 |
| Carl Ashley Morris | Chief Scientific Officer | 2023年1月27日 M | 19760 | 0 | 0 | $0 |
| Erin Powers Brennan | Chief Legal Officer, Secretary | 2022年5月2日 A | — | 0 | 0 | $0 |
| Lynette Herscha | Chief Legal Officer | 2020年7月27日 M | 160859 | 0 | 0 | $0 |
| Jorge Armando Quiroz | Chief Medical Officer | 2019年1月23日 A | 228092 | 0 | 0 | $0 |
| Ian F Smith | 董事 | 2026年7月2日 M | 138145 | 0 | 0 | $0 |
| Clare Kahn | 董事 | 2026年6月10日 A | 2960 | 0 | 0 | $0 |
| Georgia Keresty | 董事 | 2026年6月10日 A | — | 0 | 0 | $0 |
| Lynne Marie Sullivan | 董事 | 2026年6月10日 A | — | 0 | 0 | $0 |
| Ilan Ganot | 董事 | 2026年6月10日 A | 27474 | 0 | 5 | $-82352 |
| Adam Leo Stone | 董事 | 2026年6月10日 A | — | 0 | 0 | $0 |
| Martin I Freed | 董事 | 2026年6月10日 A | 53763 | 0 | 0 | $0 |
| Sukumar Nagendran | 董事 | 2026年6月10日 A | 34258 | 0 | 0 | $0 |
| Adam Koppel | 董事 | 2024年1月11日 A | 4034582 | 0 | 0 | $0 |
| Robert Luther Huffines | 董事 | 2022年12月13日 A | — | 0 | 0 | $0 |
| Rajeev Shah | 董事 | 2021年6月16日 A | 8709882 | 0 | 0 | $0 |
| Matthew Bennett Arnold | 董事 | 2020年12月10日 A | 3933429 | 0 | 0 | $0 |
| Juan Andrey Zarur | 董事 | 2020年1月2日 A | 10189 | 0 | 0 | $0 |
| Boxer Capital, LLC | 10% 所有者 | 2019年3月28日 S | 3473272 | 0 | 0 | $0 |
| Gilad David Hayeem | 10% 所有者 | 2018年8月22日 G | 1948991 | 0 | 0 | $0 |
| Joel Solomon Zev Schneider | — | 2022年3月14日 S | 236270 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd., Perceptive Xontogeny Venture Fund, LP ×11 申报 | 2026年8月14日 | 11.20% | 修订 | — | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×12 申报 | 2026年6月24日 | 11.90% | 修订 | — | SEC |
| BCLS SB Investco, LP, Bain Capital Life Sciences Fund II, L.P., BCLS II Investco, LP, BCIP Life Sciences Associates, LP, BCLS II Equity Opportunities, LP, Bain Capital Life Sciences Opportunities IV, L.P. ×12 申报 | 2026年3月10日 | 8.80% | 修订 | — | SEC |
| RA Capital Management, LLC, Peter Kolchinsky ×2 申报 | 2019年7月30日 | — | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 32 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BIB · ProShares Trust | 0.03% | 2880 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 263560 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 2775 NS | 2026年5月31日 | N-PORT |
| UWM · ProShares Trust | 0.01% | 2170 NS | 2026年5月31日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.00% | 18153 NS | 2026年5月31日 | N-PORT |
| URTY · ProShares Trust | 0.00% | 2193 NS | 2026年5月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 2475 NS | 2026年4月30日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 7422 NS | 2026年4月30日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2366 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.00% | 55 NS | 2026年5月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 19273 NS | 2026年4月30日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 2692 NS | 2026年4月30日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 17135 NS | 2026年4月30日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 957 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| ITOT · iShares Trust | — | — | 2026年7月22日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWN · iShares Trust | — | — | 2026年8月17日 | 每日 |
| IWO · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IBB · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWC · iShares Trust | — | — | 2026年8月18日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026年7月13日 | 每日 |
| VHT · VANGUARD WORLD FUND | — | — | 2026年7月20日 | 每日 |
| IBRN · iShares Trust | — | — | 2026年8月6日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | — | — | 2026年7月20日 | 每日 |